Yunlong Cui
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Chemotherapy combined with immunotherapy vs. chemotherapy: comparison of safety and efficacy in adjuvant therapy for intrahepatic cholangiocarcinoma.
Journal: Frontiers in oncology
Published: December 10, 2025
Integrative profiling of transcriptome and metabolome of skeletal muscle after endurance exercise in a high-fat diet.
Journal: Clinics (Sao Paulo, Brazil)
Published: November 18, 2025
Preparation and Properties of High-Loading Solvent-Free Dry Electrodes in LiFePO4 Lithium-Ion Batteries.
Journal: Langmuir : the ACS journal of surfaces and colloids
Published: September 25, 2025
Presence of symptoms predicts poor survival and correlates with COX-2 expression in resected intrahepatic cholangiocarcinoma patients.
Journal: Medicine
Published: September 01, 2025
Integrated Multi-Omics Profiling Identifies an Immunotherapy Vulnerable and Prognostic Associated Subtype in Cholangiocarcinoma.
Journal: Liver cancer
Published: August 26, 2025
Perioperative tislelizumab plus lenvatinib treatment for resectable hepatocellular carcinoma at high risk of recurrence: single-arm phase II trial.
Journal: Nature communications
Published: July 12, 2025
Laparoscopic vs. open liver resection for malignancies involving segment 7: short-term outcomes and learning curve analysis using propensity score matching.
Journal: Surgical endoscopy
Published: July 11, 2025
A LASSO Cox Regression Predictive Model for Patients Undergoing Surgery for Pancreatic Body and Tail Adenocarcinoma Patients: Comparative Long-Term Survival Analysis of Radical Antegrade Modular Pancreatosplenectomy (RAMPS) and Standard Retrograde Pancreatosplenectomy (SPRS).
Journal: Annals of surgical oncology
Published: March 19, 2024
Sintilimab, bevacizumab biosimilar, and HAIC for unresectable hepatocellular carcinoma conversion therapy: a prospective, single-arm phase II trial.
Journal: Neoplasma
Published: August 06, 2023
CDCA8 Facilitates Tumor Proliferation and Predicts a Poor Prognosis in Hepatocellular Carcinoma.
Journal: Applied biochemistry and biotechnology
Published: June 19, 2023
Hepatic Runx1t1 improves body fat index after endurance exercise in obese mice.
Journal: Scientific reports
Published: May 25, 2023
Last Updated: 09/26/2026